Table 8.
Visual field change from visual field at initial visit to 3 months, 6 months, and 1 year from first visit
| Time from first visit /Initial Visual Field | Steroid started ≤2 weeks from onset (n=261 eyes) |
Steroid started >2 weeks from onset (n=101 eyes) |
||||
|---|---|---|---|---|---|---|
| n** | Number (%) of eyes |
n** | Number (%) of eyes |
|||
| Improved | Worsened | Improved | Worsened | |||
| 3 months* | (n=256) | (n=99) | ||||
| Minimal | 10 | — | 7 (70%) | 6 | — | 1 (17%) |
| Mild | 66 | 20 (30%) | 18 (27%) | 23 | 7 (30%) | 5 (22%) |
| Moderate | 59 | 15 (25%) | 12 (20%) | 21 | 1 (5%) | 5 (24%) |
| Marked | 85 | 28 (32%) | 15 (18%) | 33 | 13 (39%) | 6 (18%) |
| Severe | 35 | 25 (71%) | — | 16 | 9 (56%) | — |
| Moderate to severe | 179 | 68 (38%) | 27 (15%) | 70 | 23 (33%) | 11 (16%) |
| 6 months* | (n=240) | (n=92) | ||||
| Minimal | 9 | — | 6 (67%) | 6 | — | 2 (33%) |
| Mild | 62 | 20 (32%) | 17 (27%) | 20 | 6 (30%) | 4 (20%) |
| Moderate | 56 | 14 (25%) | 12 (21%) | 21 | 1 (5%) | 5 (24%) |
| Marked | 82 | 28 (34%) | 15 (18%) | 30 | 12 (40%) | 5 (17%) |
| Severe | 31 | 25 (81%) | — | 15 | 9 (60%) | — |
| Moderate to severe | 169 | 67 (40%) | 27 (16%) | 66 | 22 (33%) | 10 (15%) |
| 1 year* | (n=215) | (n=79) | ||||
| Minimal | 8 | — | 5 (62%) | 6 | — | 2 (33%) |
| Mild | 52 | 18 (35%) | 14 (27%) | 17 | 4 (24%) | 3 (18%) |
| Moderate | 52 | 13 (25%) | 13 (25%) | 19 | 1 (5%) | 5 (26%) |
| Marked | 77 | 28 (36%) | 15 (19%) | 25 | 10 (40%) | 5 (20%) |
| Severe | 26 | 21 (81%) | — | 12 | 7 (58%) | — |
| Moderate to severe | 155 | 62 (40%) | 28 (18%) | 56 | 18 (32%) | 10 (18%) |
*
±6 weeks for 3 and 6 months; ±12 weeks for 1 year
**
n includes the eyes that have a follow-up for VF of at least the lower limit specified